Moderna Stock Jumps on Better-Than-Expected Covid-19 Vaccine Sales
Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed its full-year sales forecast. Covid vaccine sales totaled $1.8 billion for the third quarter.
Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, But RSV Shot Disappoints
While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday note to investors said sales of the company’s respiratory syncytial virus vaccine mRESVIA was significantly lower than expected.
Moderna disappoints in RSV debut, squares up with Pfizer in COVID-19 vaccine sales
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the same. | Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines,
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health and Social Care, signed a Termination and Settlement Agreement and an amendment to resolve disputes over their updated COVID-19 vaccine supply contract from July 1,
Moderna Swings to 3Q Profit, Driven by Updated Covid-19 Vaccine
The biotech company, which makes the Spikevax RNA-based Covid-19 vaccine, reported net income of $13 million, or 3 cents a share, compared with a loss of $3.6 billion, or $9.53 a share, in the same quarter last year. Analysts had forecast a loss of $1.96 a share, on average, according to FactSet.
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
Moderna reported a surprise third-quarter profit on Thursday, driven by cost-cuts and higher-than-expected sales of its COVID-19 vaccine, even with low revenue from its new respiratory syncytial virus shot.
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.
The Associated Press on MSN14m
Don't wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines
Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...
She helped thousands get COVID-19 shots. Now she's on the hook for $600K
A Kingston, Ont., doctor celebrated for organizing drive-thru vaccination clinics that helped thousands get shots at the ...
Moderna Q3 Revenue Beats On Updated COVID-19 Vaccine, Slashes Expenses For 2024
On Thursday, Moderna Inc (NASDAQ:MRNA) stock is trading higher after the company reported better-than-expected third-quarter ...
IFLScience1h
It’s Safe To Get Your COVID-19 And Flu Shots Together, Concludes New Study
The optimal time to get your seasonal flu shot, according to the Food and Drug Administration (FDA), is right now: flu ...
Hosted on MSN5h
Do COVID-19 boosters still make sense? What to know about the latest vaccine rollout
There is “no doubt,” Russell said, that there is a benefit to getting the vaccine. Ontario and other provinces have begun ...
Second dose of 2024-2025 COVID-19 vaccine recommended for these at-risk groups, CDC says
As of late October, the CDC recommends a second dose of the 2024-2025 COVID-19 vaccine for at-risk groups. Here's what you ...
The Hill13d
CDC updates COVID-19 vaccine recommendations for older adults
(NEXSTAR) — The Centers for Disease Control and Prevention is urging certain people to get additional doses of the COVID-19 ...
Doctor Gets 31 Years for Poisoning Mother's Partner With Fake COVID Vaccine
A doctor in the United Kingdom was sentenced to 31 years in prison this week after admitting to poisoning his mother's ...